Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 Diabetes Managementukmlamrcgp aktpanemrcem sbamrcp part 1prescribing safety assessment

A 55-year-old woman with type 2 diabetes, managed with metformin 1g BD and gliclazide 80mg BD, has an HbA1c of 68 mmol/mol (target is 53 mmol/mol). Her eGFR is >60 mL/min/1.73m^2 and BMI is 32 kg/m^2. According to NICE NG28, what is the most appropriate next agent to add?

Educational content. Not a substitute for clinical judgement or local policy.